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Objectives: In cT1-2N0, oral squamous cell carcinoma (OSCC) occult metastases are
detected in 23%-37% of cases. Sentinel lymph node biopsy (SLNB) was introduced
in head and neck cancer as a minimally invasive alternative for an elective neck dis-
section in neck staging. Meta-analyses of SLNB accuracy show heterogeneity in the
existing studies for reference standards, imaging techniques and pathological exami-
nation. The aim of this study was to assess the sensitivity and negative predictive
value (NPV) of the SLNB in detecting occult metastases in cT1-2N0 OSCC in a
well-defined cohort.
Design: Retrospective study. The SLNB procedure consisted of lymphoscintigraphy,
SPECT/CT-scanning and gamma probe detection. Routine follow-up was the refer-
ence standard for the SLNB negative neck. Histopathological examination of sen-
tinel lymph nodes (SLN) consisted of step serial sectioning, haematoxylin-eosin and
cytokeratin AE1/3 staining.
Setting: Two comprehensive oncology centres.
Participants: A total of 91 consecutive patients with primary cT1-2N0 OSCC trea-
ted by primary resection and neck staging by SLNB procedure between 2008 and
2016.
Main outcome measures: Sensitivity and negative predictive value.
Results: In all cases, SLNs were harvested. A total of 25 (27%) patients had
tumour-positive SLNs. The median follow-up was 32 months (range 2-104). Four
patients were diagnosed with an isolated regional recurrence in the SLNB negative
neck side resulting in an 85% sensitivity and a 94% NPV.
Conclusion: In our cohort, the SLNB detected occult metastases in early OSCC with
85% sensitivity and 94% NPV. This supports that SLNB is a reliable procedure for
surgical staging of the neck in case of oral cT1-2N0 SCC.
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1 | INTRODUCTION
Regional metastases occur in 23%-37% of the early stage (cT1-2N0)
oral squamous cell carcinomas (OSCC).1-3 Lymph node status is an
important prognostic factor for outcome and treatment decision-mak-
ing of head and neck cancer.1-8 However, not all metastases are clini-
cally detectable with the current diagnostic modalities.9-11 Occult
metastases are conventionally treated by removal of the lymph nodes
by elective neck dissection (END) after research showed higher rates
of overall and disease-specific survival compared to a watchful waiting
strategy.12 However, an END has disadvantages: it leads to overtreat-
ment in 63%-77% of the cases and has a risk of postoperative comor-
bidity (eg shoulder pain, reduced limb movement).13 Therefore, there
is a need for a better neck staging modality.
The sentinel lymph node biopsy (SLNB) was introduced in oral
cavity cancer as a less invasive lymph node staging technique after
successful implementation in melanoma and breast cancer.5 The
limited number of lymph nodes (LN) with the SLNB enables a more
meticulous pathological examination incorporating step serial sec-
tioning (SSS) and additional immunohistochemistry (IHC).14
Recently, Liu and Wang reported a meta-analysis of 3566 early
stage OSCC patients from 66 studies with a pooled sensitivity of
87% and negative predictive value (NPV) of 94% for SLNB in
detecting occult metastasis.15 However, many of these studies con-
sist of small cohorts and differ in reference treatment, SLNB locali-
sation technique (eg use of gamma probe, blue dye or single
photon emission CT (SPECT-CT)) and pathological work-up (with or
without IHC or SSS). Furthermore, several studies provide incom-
plete clinico-pathological information. This heterogeneity and lack
of complete data underline the need for more studies using com-
plete and homogeneous cohorts. The aim of this study was to
determine the sensitivity and NPV of the SLNB in detecting occult
metastases in a large, well-defined cohort. For this purpose, we
used a retrospective cT1-2N0 OSCC cohort of 91 patients all trea-
ted by primary surgical resection, neck staging with the SLNB pro-
cedure and routine follow-up as reference standard for the SLNB
negative neck.
2 | PATIENTS AND METHODS
2.1 | Ethical consideration
Sentinel lymph node biopsy was part of standard treatment and data
were retrospectively gathered from existing data sources; therefore,
no approval from the hospital research ethics board was required
according to the Dutch ethical regulations.16,17
2.2 | Patients and setting
Patients treated at the Oral & Maxillofacial Surgery or Otorhinolaryn-
gology/Head & Neck Surgery departments of the University Medical
Center Groningen (UMCG) (n = 83) or the Oral & Maxillofacial
Surgery department of the Medical Center Leeuwarden (MCL) (n = 8)
between October 2008 and December 2016 were used for analysis.
Detailed information about the patient selection and the SLNB proce-
dure are added to this manuscript as Appendix S1.
Briefly, inclusion criteria were as follows: clinically T1-2 and N0
staged OSCC (7th TNM classification); primary treatment by surgical
resection and neck staging by SLNB. Clinico-pathological data of the
91 (100%) patients were retrospectively collected from the digital
patients files (Table 1). Cases with a positive SNLB underwent a modi-
fied radical neck dissection (MRND) during a second surgery. Routine
follow-up of the neck was used as reference standard in the SLNB
negative patients and consisted of physical examination that was fol-
lowed by ultrasound fine needle aspiration cytology (USFNAC) in case
of enlarged (>1 cm) or otherwise suspicious lymph nodes.
2.3 | Study procedure
The SLNB procedure was described in detail before and was mostly
the same in both centres.18 Lymphoscintigraphy and SPECT/CT
scans were made 1 day before surgery. Intraoperatively, SLNs were
harvested after gamma probe assisted localisation.18 SLNs were
histopathologically examined by SSS with an interval of 500 lm and
additional pan-cytokeratin antibody (AE 1/3) immunohistochemistry
staining. Additional lymph nodes (non-SLNs) were harvested if they
blocked the SLN or formed a conglomerate with the SLN.
2.4 | Statistical analysis
IBM SPSS Statistics 23 (Statistical Package for the Social Sciences,
Inc., Chicago, IL, USA) was used for analysis. Categorical data are pre-
sented as number (n) and their percentages (%). Associations between
categorical data were tested with the Fisher’s exact or Chi-squared
test. Continuous data were tested using the Student’s t test or the
Mann-Whitney U test for normally or skewed distributed data, respec-
tively. False negative SLNB patients were defined as patients with iso-
lated regional recurrence in the SLNB negative neck side and were
used to calculate the sensitivity and negative predictive value. Signifi-
cant differences were defined as a P-value ≤.05.
Keypoints
• The sentinel lymph node biopsy detected occult metas-
tases in our cN0 cohort with an 85% sensitivity and a
94% negative predictive value.
• No additional metastases were seen in the neck dissec-
tion lymph nodes of patients with micrometastases or
isolated tumor cells in the sentinel lymph nodes.
• The sentinel lymph node biopsy reveals unexpected lym-
phatic drainage patterns and therefore prevents patients
for undertreatment of the neck.
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3 | RESULTS
Sentinel lymph nodes were identified in all 91 cases (100%). In total,
274 SLNs were harvested with a median of 3 (range 1-11) per
patient. The results of the SLN procedures are summarised in
Table 1. In all patients, at least one SLN was intraoperatively
detected. However, in 4 patients (4%), additional hotspots were
noticed besides the harvested SLNs on the SPECT-CT without intra-
operative detectable radioactive LNs. In 1 of these 4 patients, the
harvested SLN was positive and the neck was treated by MRND in a
second operation. The other 3 patients were isolated regional recur-
rence (IRR) free after 10, 11 and 47 months of routine follow-up. In
1 patient with a ventral floor of mouth tumour, only a contralateral
SLN was identified. The other patients had ipsilateral (n = 57, 63%)
or bilateral (n = 33, 36%) located SLNs.
Positive SLNs were found in 25 (27%) patients. In 1 patient with
a 1 mm metastasis in the SLN routine follow-up was chosen instead
of a MRND. This patient was still recurrence free after 23 months.
In none of the patients with micrometastases or ITCs in the SLN,
additional metastases were found in the MRND specimen (Figure 1,
Table 2, P = .024). Also, none of the 57 non-SLNs harvested during
the SLNB were positive. Finally, skip metastases were not seen: all
patients with positive SLNs had at least one positive SLN in level I-
III. Infiltrative tumour border configuration (P = .008) and pT2
tumour stage (P = .036) showed an association with lymph node sta-
tus (Table 1).
3.1 | Follow-up and regional recurrence
Overall the median FU was 32 months (IQR 21-47, Range 2-104,
Table 1). All patients with a follow-up <10 months died. In total,
8 (9%) patients of this cohort died. Three patients died of
disease, two 10 months and one 21 months after the initial treat-
ment.








valuepN0, n (%) pN+, n (%)
Total 91 (100) 66 (100) 25 (100) NA
Sex
Male 43 (48) 32 (48) 11 (44) .815
Female 48 (52) 34 (52) 14 (56)
Age at first treatment, y
Median (IQR) 62 (56-70) 61 (56-71) 64 (57-69) .996
Tumour location n (%)
Tongue 52 (57) 35 (53) 17 (68) .111a
FOM 27 (30) 23 (35) 4 (16)
Cheek mucosa 8 (9) 5 (8) 3 (12)
Upper gum 3 (3) 2 (3) 1 (4)
Lower gum 1 (1) 1 (2) 0 (0)
cT classification
cT1 66 (73) 51 (77) 15 (60) .119
cT2 25 (27) 15 (23) 10 (40)
pT classification
pT1 73 (80) 57 (86) 16 (64) .036
pT2 18 (20) 9 (14) 9 (36)
SLNB side
Ipsilateral 57 (63) 40 (61) 17 (68) .701
Contralateral 1 (1) 1 (2) 0 (0)
Both sides 33 (36) 25 (38) 8 (32)
Number of SLNs per patient
Median (IQR) 3 (2-4) 3 (2-4) 3 (2-4) .585
Tumour infiltration depth
<4.59 mm 59 (65) 46 (70) 13 (52) .142
≥4.59 mm 32 (35) 20 (30) 12 (48)
Perineural invasion
Yes 6 (7) 3 (5) 3 (12) .340
No 85 (93) 63 (95) 22 (88)
Lymphovascular invasion
Yes 9 (10) 6 (9) 3 (12) .702
No 82 (90) 60 (91) 22 (88)
Tumour border configuration
Pushing 54 (59) 45 (68) 9 (36) .008
Infiltrative 37 (41) 21 (32) 16 (64)
Differentiation grade
Well 29 (32) 21 (32) 8 (32) 1.000















valuepN0, n (%) pN+, n (%)
Recurrence
Local/2nd primary 9 (10) 5 (8) 4 (16) b
Isolated regional rec. 5 (5) 2 (3) 3 (12)
Dead
Dead of disease 3 (3) 0 (0) 3 (12) b
Dead not of disease 7 (8) 6 (9) 1 (4)
FOM, floor of mouth; IQR, interquartile range; NA, not applicable; pN0,
SLNs negative for metastases; pN+, SLNs positive for metastases; Rec,
recurrence; SLNB, sentinel lymph node biopsy.
aTongue vs floor of mouth, other subgroups too small to analyse.
bGroup too small to analyse.
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Local recurrence and second primary tumours, with or without
regional recurrence, were seen in 9 (10%) cases. Isolated regional
recurrence was detected in 5 (5%) patients. One of these patients
had IRR after a positive SLN and subsequent neck dissection at that
neck side. The other 4 patients were diagnosed with IRR after 4, 6,
9 and 19 months. Their tumour, treatment and recurrence character-
istics are shown in Table 3. The first patient had a positive ipsilateral
SLN and was 4 months later diagnosed with level I and level II IRRs
at the contralateral side. Revision of the SPECT-CT images and the
conventional CT images of the IRR did not reveal new insights. The
second patient had ipsilateral negative SLNs and was diagnosed with
level Ib and level IV IRRs after 9 months. Revision of the SPECT-CT
images of this patient showed a lymph node with a diameter of
7 mm without radioactivity just at the inside of the mandibular angle
in level Ib. This lymph node was most likely not resected during the
SLNB procedure and could be the same as the IRR lymph node. The
third patient had a positive contralateral SLN. IRR occurred on the
ipsilateral side, which was SLNB negative and was therefore not
treated by MRND. Revision of the lymphoscintigraphy images
revealed a low signal in level Ib at the ipsilateral side, what might be
a missed SLN. The fourth patient had a negative SLN in level II and
was diagnosed with IRR in level Ib, both ipsilateral. Revision of the
SPECT/CT scan showed a LN within the radioactive hotspot of the
floor of mouth tumour of this patient. Most likely, this is the same
LN in which the IRR was diagnosed (Figure 2).
Due to the four IRRs, the SLNB detected occult metastases with
85% sensitivity and 94% NPV.
4 | DISCUSSION
4.1 | Synopsis of key findings
In our retrospective cohort of 91 patients treated for cT1-2N0
OSCC, 4 patients developed isolated regional recurrence on the side
of a negative SLNB. This resulted in 85% sensitivity and 94% nega-
tive predictive value.
4.2 | Comparison to previous studies
The sensitivity and NPV are in agreement with the results of other
studies with routine follow-up as a reference: sensitivity range 80%-
94% and NPV range 88%-97.5% (number of patients 59-415).1,6-8,19
A recent meta-analysis also showed comparable results: sensitivity
87%, NPV 94%.15 The slightly higher NPV of this cohort compared
to these meta-analyses can be explained by the relative short fol-
low-up of some patients in our cohort. Two of the 66 patients (3%)
with routine follow-up after a negative SLNB were diagnosed with
IRR. This percentage is much lower than the conventional 20%
change of having IRR from Weis et al20, which is generally used in
literature as threshold to choose between watchful waiting and
END. The low percentage IRR indicates the accurate selection of
cT1-2N0 patients for neck dissection or routine follow-up by per-
forming a SLNB.
False negativity was defined as patients with IRR in an earlier
SLNB negative neck side, regardless of a positive SLNB on the other
side of the neck. Four (4%) patients in our cohort were diagnosed
with IRR in a SLNB negative side of the neck, which is comparable
Oral squamous cell carcinoma
Inclusion criteria
- cT1-2N0 And pT1-2
- First primary head neck tumour 
- Surgical resection of the tumour
























F IGURE 1 Flow chart of the UMCG and MCL cT1-2N0 oral
squamous cell carcinoma cohort. In total, 91 patients were used for
analysis. A total of 25 patients had metastasis positive SLNB. Two
patients with pN0 and 2 patients with pN+ SLNB neck status were
diagnosed with isolated regional recurrence in the SLNB negative
neck side. MRND, modified radical neck dissection; pN0, All SLNs
negative for metastasis; pN+, at least one SLN positive for
metastasis; SLNB, sentinel lymph node biopsy
TABLE 2 Association between SLN metastasis size and additional
metastases in modified radical neck dissection lymph nodes
SLN status n (%)
HKD lymph node status
P valuepN-, n (%) pN+, n (%)
Isolated tumour cells 7 (29) 7 (37) 0 (0) .024
Micrometastases 6 (25) 6 (32) 0 (0)
Macrometastases 11 (46) 6 (32) 5 (100)
MRND, modified radical neck dissection; pN0, SLNs negative for metas-
tases; pN+, SLNs positive for metastases; SLN, sentinel lymph node.
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with other studies.6,8 Retrospectively, the reason for missing these
regional metastases remains unclear; shine-through phenomenon and
aberrant lymphatic drainage due to metastatic tumour in the SLNs
might be involved. Another possible explanation might be
micrometastases in lymph nodes, other than the SLN (skip metas-
tases).
Other studies reported a lower sensitivity of the SLNB procedure
in FOM tumours compared to other oral cavity subsites due to the
shine-through phenomenon.7,8,21,22 One patient in this study had a
FOM with an IRR resulting in an 80% sensitivity and a 96% NPV for
FOM tumours. Retrospectively, this SLNB was overlooked because
of this shine-through phenomenon (Figure 2). To overcome shine-
through and subsequent regional recurrences, Stoeckli et al23 pro-
posed a surgical technique with dissection of all the LNs in level I
irrespective of the location of the SLNs. Van den Berg et al24 com-
bined the SLNB procedure with radio and fluorescence guidance and
found this combination especially helpful in detecting SLNs located
close to the primary tumour. Our data support the findings of the
F IGURE 2 Shine-through phenomenon example. Patient with floor of mouth tumour on the left side closes the midline (A), with a lymph
node within the tumour hotspot (B) and an isolated regional recurrence after 19 mo (C)
TABLE 3 Characteristics of the 4 patients with isolated regional recurrence
Variables
Patients with isolated regional recurrence
1 2 3 4
Tumour Tongue Cheek mucosa Tongue FOM
pT classification 1 1 2 2
Infiltration depth (mm) 8 5.0 3.7 2.7
Border growth Pushing Infiltrative Infiltrative Infiltrative
Resection margins Free Free Free Free
Perineural growth or Lympho-/angioinvasion Yes, both No No No
Differentiation grade Good Moderate Moderate Moderate
Reresection Yes No No No
Postoperative radiotherapy Tumour & Neck No No No
SLNB side Ipsilateral Ipsilateral Both Both
Positive SLN side Ipsilateral NA Contralateral NA
MRND side Ipsilateral NA Contralateral NA
Regional recurrence side Contralateral Ipsilateral Ipsilateral Ipsilateral
Number of SLNs recurrence side NA 3 1 1
Number of positive SLNs recurrence side NA 0 0 0
SLN level recurrence side NA Level II Level II Level II
Recurrence level Level I + II Level Ib + IV Level Ib, II, IV Level Ib
Number of LNs (positive/total) 2/44 (ENE+) 6/41 4/46 NAa
Maximum diameter regional recurrence metastasis (mm) 25 12 15 13a
Time between 1st treatment and rec. (mo) 4 9.2 5.5 19
Total follow-up (mo) 27 36 9 25
Dead of disease NA NA Yes NA
ENE, extranodal extension; MRND, modified radical neck dissection; NA, not applicable; SLNB, sentinel lymph node biopsy.
aThe isolated regional recurrence of patient 4 was not operatively removed; therefore, only clinical data were available.
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previously mentioned studies23,24 that patients with primary tumours
adjacent to level I could benefit from additional techniques besides
the SLNB procedure alone.
The upstaging rate in this study (27%) is in agreement with the
literature; 23%-37%.1,2,7,8 We found no additional metastasis in the
MRND lymph nodes after a SLNB positive for ITCs or micrometas-
tases. Recently, den Toom et al reported that the ratio of positive vs
negative SLNs and the size of the tumour in the SLN possibly could
be predictive factors for non-SLN metastasis in SLN positive
patients. However, their analysis was underpowered due to the use
of the ITC, micro- and macrometastasis classification in just a few
SLNB studies.25 No additional metastasis in ITC or micrometastasis
SLN positive patients could be the reason why Liu and Wang et al15
concluded in their meta-analysis that SSS is not necessary for SLN
assessment. Despite the lack of impact of the SSS on the IRR rate,
in agreement with den Toom and our data presented in this paper,
SLN metastasis size might be used to select patients for routine fol-
low-up instead of MRND.8 Besides the SSS itself, also the step inter-
val size could be discussed. After the second international
conference on SLNB, intervals of 150 lm were recommended.26 As
was reported earlier for breast cancer, Jefferson et al suggested that
SSS intervals of 2 mm are thin enough to detect micrometasta-
sis.27,28 In this study, intervals of 500 lm were used, because our
head and neck SCC protocol was adapted from our vulvar SCC
SLNB protocol. This is a protocol we have much experience with
and has shown to provide accurate staging of vulvar SCC in our cen-
tre.29-31 Besides this, the accuracy we found is comparable to that
of most head and neck SLNB studies.15 Moreover, the ITC, micro-
and macrometastasis ratio is comparable with other studies, indicat-
ing that we did not miss ITCs using this protocol. We therefore
assume that this protocol has not influenced our results. However,
we propose to continue SSS and classification of SLN metastasis size
according to Hermanek, until well powered studies have defined the
clinical impact of the SLN metastasis size.32 Afterwards, further
research is needed to reach consensus about minimal interval thick-
ness for SSS to detect these metastases with clinical impact.
Thirty-three patients had SLNs on both sides of the neck, also in
cases with lateralised border of tongue tumours. Moreover, 1 patient
did not show ipsilateral lymphatic drainage patterns, but instead
showed a negative contralateral SLN. This patient did not develop
IRR at either side within 34 months follow-up. These 34 (37%)
patients showed the advantage of detecting unexpected drainage
patterns with the SLNB procedure and were thereby prevented from
undertreatment.
Despite the good accuracy of the SLNB procedure, improve-
ments might be made for the clinical negative neck. For example, in
our centres, the use of blue dye has been abandoned, because it
blurred surgical tumour resection margins preoperatively. A disad-
vantage of the SLNB procedure is the second operation for the
MRND after a positive SLNB. Especially in frail elderly or patients
with multiple comorbidities, a second operation with general anaes-
thesia is undesirable due to a higher complication and mortality
chance.33 Moreover, in all positive cases, scar tissue makes the neck
dissection surgery more challenging in the SLN levels. To avoid
repeat surgery, the possibility of intraoperatively staging of SLNs
with frozen sections has been studied.34 However, frozen sections
have a substantial false negative rate; therefore, frozen sections of
the SLNs are not applied in our centres. Also, a substantial amount
of the SLN is lost for the FFPE sections and thereby increasing the
risk of missing ITCs and micrometastases.34
In an ideal situation, patients at high risk of lymph node metas-
tases are preoperatively selected for MRND or watchful waiting. In
the current study, an infiltrative tumour border configuration or a
pT2 tumour was significantly associated with more regional metas-
tases. Our research group reported earlier infiltration depth and lym-
phovascular invasion as independent predictors for nodal status in
pT1-2N0 and N-status determination by routine HKD and watchful
waiting.35 These markers are not associated with positive lymph
nodes in this study. The lack of significance could be explained by
the difference in patient selection between the mentioned study by
Melchers (cN0 and cN+) and this study (cN0).35 Therefore, the SLNB
procedure is still more accurate in detecting occult metastasis in
cT1-2N0 OSCC than the current clinical and pathological markers. In
addition, it would be interesting to study the prognostic value of
OSCC lymph node status associated biological markers such as
WISP1, RAB25 or EpCAM in cT1-2N0 OSCC SLNB staged
patients.36-38
4.3 | Study limitations
Limitation of this study is that the SLNB procedure was not part of
the standard workflow for cT1-2N0 OSCC patients in the first years
after introduction. If we analyse the accuracy without the 6 patients
from this period, the sensitivity and NPV are still 85% and 94%
respectively.
5 | CONCLUSION
In this retrospective well-defined cohort consisting of 91 patients,
we showed that the sentinel lymph node biopsy is an accurate
diagnostic technique in detecting occult metastases in cT1-2N0
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